These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Rutter MM; Collins J; Rose SR; Woo JG; Sucharew H; Sawnani H; Hor KN; Cripe LH; Wong BL Neuromuscul Disord; 2012 Dec; 22(12):1046-56. PubMed ID: 22967789 [TBL] [Abstract][Full Text] [Related]
24. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648 [TBL] [Abstract][Full Text] [Related]
25. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP Arch Neurol; 1991 Apr; 48(4):383-8. PubMed ID: 2012511 [TBL] [Abstract][Full Text] [Related]
26. Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy. Lit L; Sharp FR; Apperson M; Liu DZ; Walker WL; Liao I; Xu H; Ander BP; Wong B Pharmacogenomics J; 2009 Dec; 9(6):411-8. PubMed ID: 19488064 [TBL] [Abstract][Full Text] [Related]
27. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Daftary AS; Crisanti M; Kalra M; Wong B; Amin R Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595 [TBL] [Abstract][Full Text] [Related]
29. Duchenne muscular dystrophy: Drug development and regulatory considerations. McNeil DE; Davis C; Jillapalli D; Targum S; Durmowicz A; Coté TR Muscle Nerve; 2010 Jun; 41(6):740-5. PubMed ID: 20373504 [TBL] [Abstract][Full Text] [Related]
30. Steroids in Duchenne dystrophy. Dubowitz V Neuromuscul Disord; 2013 Jul; 23(7):527-8. PubMed ID: 23743333 [No Abstract] [Full Text] [Related]
31. Eteplirsen (Exondys 51) for duchenne muscular dystrophy. Med Lett Drugs Ther; 2016 Nov; 58(1507):145-146. PubMed ID: 27805575 [No Abstract] [Full Text] [Related]
32. Exposure-Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy. Li X; Conklin LS; van den Anker J; Hoffman EP; Clemens PR; Jusko WJ J Clin Pharmacol; 2020 Oct; 60(10):1385-1396. PubMed ID: 32434278 [TBL] [Abstract][Full Text] [Related]
33. Impact of steroids on surgical experiences of patients with duchenne muscular dystrophy. Dooley JM; Gordon KE; MacSween JM Pediatr Neurol; 2010 Sep; 43(3):173-6. PubMed ID: 20691938 [TBL] [Abstract][Full Text] [Related]
34. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols. Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688 [TBL] [Abstract][Full Text] [Related]
38. Change in the natural profile of Duchenne muscular dystrophy with the judicious use of steroids. Pradhan S; Das A Neurol India; 2018; 66(3):893-895. PubMed ID: 29766977 [No Abstract] [Full Text] [Related]
39. [Therapeutic trials for Duchenne muscular dystrophy: between hopes and disappointments]. Bloetzer C; Fluss J; Jeannet PY Rev Med Suisse; 2012 Feb; 8(329):409-12. PubMed ID: 22432241 [TBL] [Abstract][Full Text] [Related]